Most Popular Stories
Poll
Featured Jobs
-
Florida Internist
StaffPointe, LLC - west , FL -
Wisconsin-Family Medicine
Ohrmund Employment Group - Cedarburg, WI -
Oklahoma Pediatrician
StaffPointe, LLC - north, OK -
Georgia Ultrasound Tech Supervisor
StaffPointe, LLC - Atlanta , GA -
New York Pulmonologist/CC
StaffPointe, LLC - east, NY
Events
- World Healthcare Innovation & Technology Congress WHIT v.4.0
Dec 8-10 — Washington, DC - World Health Care Congress
April 14-16, 2009 — Washington, DC
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Popular Topics
ALSO NOTED: Demand for health IT pros to soar; Pharmas lobbying hard in DC; and much more...
> Industry researchers are predicting that it will take a huge increase in the volume of professionals available (more than 40,000) to meet the near-term demand for skilled health IT pros. FierceHealthIT
> Pharmaceutical companies are lobbying hard for their position in Washington in the wake of the black eye they've taken with the Vytorin and Vioxx marketing scandals. FiercePharma
> Concerned by the potential for an outbreak, Japan has begun inoculating health care workers with a pre-pandemic bird flu vaccine. FierceVaccines
> Drugmakers Wyeth and Elan have suspended testing on their Alzheimer's vaccine study after one of the patients in the study developed skin lesions. FierceBiotech
And Finally... What's more interesting than man bites dog? Citizen tickets cop, of course! Article
Related Stories
- Reports suggest that Merck downplayed Vioxx risks
- Study: Nursing homes unprepared for pandemics
- ALSO NOTED: Hospital group says quality reporting too costly; Health IT 'name game' creating headaches; and much more...
- SPOTLIGHT: Group ponders how doctors should prepare for disasters
- Studies show problems with four big-name drugs
- FDA says Glaxo didn't report Avandia data
- Congress says drugmakers held back Vytorin data
- Drugmakers face direct-to-consumer ad ban
- Tamiflu ads spark criticism
- Questionnaire could cut ER visits during flu season
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





